Abbott Laboratories
NYSE:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist
Price: 117.36 USD -0.25%
Market Cap: 204.2B USD
Have any thoughts about
Abbott Laboratories?
Write Note

Abbott Laboratories
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Abbott Laboratories
Accounts Receivables Peer Comparison

Comparables:
BDX
BSX
EW
SYK
ISRG

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Abbott Laboratories
NYSE:ABT
Accounts Receivables
$6.9B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
7%
Becton Dickinson and Co
NYSE:BDX
Accounts Receivables
$2.6B
CAGR 3-Years
8%
CAGR 5-Years
3%
CAGR 10-Years
8%
Boston Scientific Corp
NYSE:BSX
Accounts Receivables
$2.5B
CAGR 3-Years
14%
CAGR 5-Years
7%
CAGR 10-Years
7%
Edwards Lifesciences Corp
NYSE:EW
Accounts Receivables
$778.3m
CAGR 3-Years
9%
CAGR 5-Years
6%
CAGR 10-Years
9%
Stryker Corp
NYSE:SYK
Accounts Receivables
$3.7B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
9%
Intuitive Surgical Inc
NASDAQ:ISRG
Accounts Receivables
$1.2B
CAGR 3-Years
18%
CAGR 5-Years
13%
CAGR 10-Years
16%

See Also

What is Abbott Laboratories's Accounts Receivables?
Accounts Receivables
6.9B USD

Based on the financial report for Sep 30, 2024, Abbott Laboratories's Accounts Receivables amounts to 6.9B USD.

What is Abbott Laboratories's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
7%

Over the last year, the Accounts Receivables growth was 5%. The average annual Accounts Receivables growth rates for Abbott Laboratories have been 2% over the past three years , 5% over the past five years , and 7% over the past ten years .

Back to Top